Recurrent Acute Leukemia
2 clinical trials · Condition
◉ Watch Recurrent Acute Leukemia
| Record | Firm | Date |
|---|---|---|
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105) | City of Hope Medical Center | 2020-11-18 |
| Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (NCT03834961) | Children's Oncology Group | 2019-10-25 |
Track Recurrent Acute Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.